Müller B, Wilsmann K
J Cardiovasc Pharmacol. 1982 Jul-Aug;4(4):615-21. doi: 10.1097/00005344-198207000-00013.
We examined the effects of the optical isomers of D 600 on cardiovascular parameters and on arrhythmias caused by aconitine infusion and ligation of left coronary artery in urethane-anesthetized rats. (-)-D 600 decreased blood pressure and LV dP/dtmax with respective Ed30% of 0.045 and 0.018 mg/kg i.v.; increased PQ duration with an ED20% of 0.045 mg/kg i.v.: and caused AV-block with an ED50 of 0.07 mg/kg i.v., thereby showing a potency 20--50 times that of (+)-D 600 and about twice that of the racemate. (+)-D 600 in the effective dose range additionally widened QRS complex (ED20%, 2.44 mg/kg i.v.) and increased arrhythmogenic aconitine dose (ED75% 4.97 mg/kg i.v.) with a potency about equal to quinidine. In contrast to the (-)-isomer and the racemate of D 600 and to (+/-)-verapamil, (+)-D 600, at a dose slightly below AV block-generating ED50 of 2.15 mg/kg i.v., significantly attenuated ventricular arrhythmias following left coronary artery ligation with a potency similar to 4.64 mg/kg i.v. quinidine but inferior to 4.64 mg/kg i.v. lidocaine. It is concluded that the optical isomers of D 600 exert stereospecific actions in vivo with respect to Ca2+-antagonistic potency. While (-)-D 600 in the effective dose range shows cardiovascular actions indicative of pure Ca2+-antagonistic properties, and activity of the racemate resides in the Ca2+-antagonistic properties of the (-)-isomer, cardiovascular effects of (+)-D 600 and its effectiveness against ventricular arrhythmias are indicative of parallel Ca2+-antagonistic and membrane-stabilizing properties.
我们研究了D 600的光学异构体对氨基甲酸乙酯麻醉大鼠的心血管参数以及由乌头碱输注和左冠状动脉结扎引起的心律失常的影响。(-)-D 600静脉注射时降低血压和左心室dp/dtmax,其各自的半数有效剂量(ED30%)分别为0.045和0.018mg/kg;静脉注射时增加PQ间期,半数有效剂量(ED20%)为0.045mg/kg;静脉注射时引起房室传导阻滞,半数有效剂量(ED50)为0.07mg/kg,因此其效力比(+)-D 600高20 - 50倍,约为消旋体的两倍。有效剂量范围内的(+)-D 600还会额外增宽QRS波群(静脉注射半数有效剂量(ED20%)为2.44mg/kg)并增加致心律失常的乌头碱剂量(静脉注射75%有效剂量(ED75%)为4.97mg/kg),其效力约与奎尼丁相当。与D 600的(-)-异构体、消旋体以及(±)-维拉帕米不同,静脉注射剂量略低于产生房室传导阻滞的半数有效剂量(ED50)2.15mg/kg时,(+)-D 600能显著减轻左冠状动脉结扎后的室性心律失常,其效力与静脉注射4.64mg/kg奎尼丁相似,但低于静脉注射4.64mg/kg利多卡因。结论是,D 600的光学异构体在体内对钙拮抗效力发挥立体特异性作用。虽然有效剂量范围内的(-)-D 600表现出指示纯钙拮抗特性的心血管作用,且消旋体的活性存在于(-)-异构体的钙拮抗特性中,但(+)-D 600的心血管作用及其对室性心律失常的有效性指示了平行的钙拮抗和膜稳定特性。